Aroa Biosurgery

Soft-tissue repair company commercializing regenerative tissue substitutes based on their proprietary Endoform platform.

Aroa Biosurgery (Aroa) is a privately held regenerative medicine company applying its proprietary Endoform extracellular matrix (ECM) technology and biomaterials expertise to develop, commercialize and market products for soft tissue repair. Having gained FDA 510k clearance in 2010 for Endoform Dermal Template (EDT) and successfully launching in 2012, EDT is now one of the leading wound care products in its category. More recently, Aroa has developed and commercialized a range of surgical products, specifically designed for use in hernia repair and abdominal wall reconstruction. Aroa continues to work with leading surgeons, clinicians, nurses and researchers throughout the world to develop and commercialize further innovations in regenerative medicine.